ANIP - ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82 revenue of $106.79M beats by $23.31M
2023-05-08 06:56:54 ET
- ANI Pharmaceuticals press release ( NASDAQ: ANIP ): Q1 Non-GAAP EPS of $1.17 beats by $0.82 .
- Revenue of $106.79M (+65.6% Y/Y) beats by $23.31M .
- Raises Company net revenue guidance to $385 million to $410 million from $360 million to $385 million vs $371.3M consensus; adjusted non-GAAP EBITDA guidance to $97 million to $107 million from $78 million to $88 million; adjusted non-GAAP earnings per share to $2.99 to $3.45 from $2.09 to $2.59 vs $2.43 consensus
For further details see:
ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31M